Home / Resource Library / EHA 2019 | Ibrutinib in early and late CLL: news from EHAEHA 2019 | Ibrutinib in early and late CLL: news from EHA EHA 2019: Summary of various studies investigating ibrutinib for treatment of chronic lymphocytic leukemia.